Get Started

TGTX

NASD TG Therapeutics, Inc.
Nov 3, 2026 · 12:46 PM ET DELAYED Market Open

$61.17 ↑ +1.22 (+2.04%) Trading Up from the previous close of $59.95, $1.03 below the day’s high of $62.20

YTD change
+105.20%
vs 20-day SMA
+10.82%
vs 200-day SMA
+39.17%

Price ranges

Previous day
$59.59 $63.60
open $61.01 close $59.95
-$1.06 (-1.74%)
Today
$60.02 $62.20
open $60.06 now $61.17
+$1.11 (+1.85%)
Past week
$53.88 $63.60
from $54.79 now $61.17
+$6.38 (+11.64%)
Past month
$51.34 $63.60
from $53.91 now $61.17
+$7.26 (+13.47%)
This year
$26.76 $63.60
from $29.81 now $61.17
+$31.36 (+105.20%)

Price & Performance

+24.25 (+67.90%) / 6M

$33.67$43.52$53.37$63.22May 4Aug 4Nov 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 3.8% away from all-time highs of $63.60
  • TGTX is up 105% since the beginning of the year
  • TGTX is up 82% over the past 12 months
  • TGTX is up 13% over the past 1 month
  • 21% of all TGTX investors are betting against TGTX

TGTX reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +77.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $0.05
Earnings momentum +86.4% Quarterly EPS growth
Quarterly change +86.4%

Valuation

P/E ratio 22.25
Enterprise value $9.6B
Beta 1.17

Balance sheet & scale

Income$441.5K
Revenue$799.5M
Cash$552.2M
Debt$754.4K
Income / Debt 0.59×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $9.4B

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

Competitor comparison

TickerCompany PriceChange
REGN Regeneron Pharmaceuticals, Inc. $961.26 +3.60%
IQV IQVIA Holdings Inc $258.44 -3.33%
CRL Charles River Laboratories International, Inc. $338.54 -5.81%
ICLR ICON Plc $205.14 -2.94%
IT Gartner, Inc. $235.26 +2.83%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.